| 4 entries found. Viewing page 1 of 1. |
| |
| September 09, 2010 |
| Zarah, a New Generic Form of Yasmin, to Be Sold in the U.S. |
| Posted By DeCarli Law |
 |
Bad news for women’s health: yet another generic form of the oral contraceptive Yasmin will be sold in the United States. Watson Pharmaceuticals, Inc. announced on Tuesday that it has received approval from the F.D.A. to sell Zarah, a generic version of
Yasmin.
Watson Pharmaceuticals obtained permission to market Zarah in the U.S. by using a procedure called an Abbreviated New Drug Application. This procedure is used to secure approval for generic drugs, and generally does not include any animal or human data to establish the drug’s safety and effectiveness.
Yasmin was previously available in generic form under the name Ocella. Yasmin, Ocella and now
Zarah contain
drospirenone and ethinyl estradiol.
Drospirenone is a synthetic progestin that acts as a potassium-sparing diuretic. This means that women using Yasmin, Ocella and
Zarah run the risk of developing abnormally high potassium levels in their bodies, which can lead to
gallbladder disease,
pulmonary embolism (PE),
deep vein thrombosis (DVT), stroke, heart attacks, and even death. Another similar birth control formulation that also comes with these risks is
YAZ, manufactured by Bayer Healthcare Pharmaceuticals.
Read HERE
to learn more about
Zarah and its risks.
Thousands of women have been injured by YAZ, Yasmin and Ocella side effects, and unfortunately, more women will now be at risk from
Zarah. If you or a loved one has suffered from any of the above side effects after using
Zarah, Yasmin, Ocella or YAZ, contact the Zarah lawyers and YAZ attorneys at DeCarli Law to learn your legal options. We provide free, no-obligation telephone consultations. You will be able to speak to an attorney, not a legal assistant or other support staff member. If we take your case, you will have no obligation to pay us fees unless we obtain a recover for you.
|
|
| Continue reading "Zarah, a New Generic Form of Yasmin, to Be Sold in the U.S." » |
|
Permalink  |
| |
| January 08, 2010 |
| 8th Circuit Removes Roadblock for Ocella Injury Lawsuits |
| Posted By DeCarli Law |
|
A recent decision from the 8th Circuit Court of Appeals has removed a barrier to women filing lawsuits for side effects from Ocella birth control.
Ocella is the generic version of the oral contraceptive Yasmin. Drug manufacturers have taken the position that injured people cannot sue them when their generic drug labels fail to adequately warn of dangerous side effects. The manufacturers claim that federal law requires them to have the same warning label on the generic version of their drugs that originally appeared on the name-brand version, and they cannot add additional warnings. The manufacturers rely on a legal doctrine called “preemption,” arguing that because their warning label has been approved by the FDA, federal law bars lawsuits against them for not warning of side effects not listed on the label.
A recent 8th Circuit Court of Appeals decision rejected this argument. Mensing v. Wyeth (2009). The plaintiff, Gladys Mensing, had developed tardive dyskinesia after taking metoclopramide, the generic form of Reglan. The generic drug manufacturers succeeded in convincing the district court to dismiss Ms. Mensing’s claims against them, but the 8th Circuit reversed. “If Mensing's injuries resulted from their failure to take steps to warn their customers sufficiently of the risks from taking their drugs, they may be held liable,” the Court of Appeals wrote. You can read the entire decision HERE.
Because Ocella is a generic drug like metoclopramide, this decision forecloses manufacturers from making the preemption argument in cases brought by women injured by Ocella. The 8th Circuit is the federal appellate court that hears appeals from federal district courts located in Arkansas, Iowa, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota. This means that when failure-to-warn claims arising from Ocella are filed in federal courts in these states, the manufacturers will not be able to argue that they are prohibited by federal law.
Ocella, Yasmin and YAZ are oral birth control pills that have a heightened risk of deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, heart attack, gallbladder disease, and even death. If you or someone you know has suffered one or more of these side effects, please consider calling the attorneys at DeCarli Law for a free, no obligation telephone consultation. You can learn more about the dangers of YAZ, Yasmin and Ocella HERE. |
|
| Continue reading "8th Circuit Removes Roadblock for Ocella Injury Lawsuits" » |
|
| Permalink |
| |
| November 10, 2009 |
| Movement Toward Consolidation of New Jersey YAZ, Yasmin and Ocella Side Effect Lawsuits |
| Posted By DeCarli Law |
|
The New Jersey Law Journal has reported that New Jersey YAZ, Yasmin and Ocella lawsuits may be consolidated before a single judge. The New Jersey judiciary is considering a request from Judge Donald Volkert Jr. of Prossaic County, New Jersey, that YAZ, Yasmin and Ocella lawsuits be given mass tort status.
13 lawsuits for injuries from YAZ, Yasmin and Ocella birth control pills are pending in Prossaic County, and 26 lawsuits are pending in other New Jersey counties. Judge Volkert wrote the Acting Administrative Director of the Courts in New Jersey on October 22, 2009, requesting mass tort status. The Administrative Office of the Courts has since issued a notice that it will accept public comments on Judge Volkert’s proposal through the end of this year.
If mass tort status is granted, the cases will be consolidated in one of three New Jersey counties where mass torts are heard: Atlantic County, Bergen County, or Middlesex County. Selection of a specific county and judge can have a significant impact on claims made by women injured by YAZ, Yasmin or Ocella. Injured women may have other options, such as filing their claims in federal court, or in the courts of other states such as California.
YAZ, Yasmin and Ocella birth control pills can cause pulmonary embolism (PE), deep vein thrombosis (DVT), stroke, heart attacks, hyperkalemia, gallbladder disease, and even death. The risk of blood clots (thrombosis) is twice as great with YAZ/Yasmin/Ocella as it is with older birth control pills. Likewise, unlike YAZ/Yasmin/Ocella, older forms of birth control pills have virtually no risk of gallbladder disease or hyperkalemia. You can learn more about the side effects of YAZ/Yasmin/Ocella, and about YAZ lawsuits, HERE.
If you or a loved one has died, suffered a stroke, blood clot, heart attack, arrhythmia or had their gallbladder removed after using YAZ, Yasmin or Ocella oral contraceptives, contact the YAZ lawyers of DeCarli Law for a free consultation.
|
|
| Continue reading "Movement Toward Consolidation of New Jersey YAZ, Yasmin and Ocella Side Effect Lawsuits" » |
|
| Permalink |
| |
| October 19, 2009 |
| Multidistrict Litigation (“MDL”) Court Created for YAZ Birth Control Lawsuits |
| Posted By Bob DeCarli |
|
On October 1, 2009, the United States Judicial Panel on Multidistrict Litigation issued an order consolidating lawsuits involving YAZ, Yasmin and Ocella birth control pills. The YAZ multidistrict litigation, or “MDL,” is assigned to the Honorable David R. Herndon, Chief Judge of the Southern District of Illinois.
All personal injury cases filed by women hurt by YAZ, Yasmin and Ocella in federal courts throughout the country will now be transferred to the Southern District of Illinois for coordinated or consolidated pretrial proceedings before Chief Judge Herndon. This includes lawsuits brought by women who have suffered heart attacks, strokes, pulmonary embolism (PE), deep vein thrombosis (DVT), gallbladder disease, and death. The YAZ MDL will also include a putative class action based on the advertising and marketing of YAZ.
An MDL is a special legal procedure used in United States Federal Courts. It is designed to speed up the process of handling complex cases, including pharmaceutical litigation arising from dangerous drugs. Cases included in an MDL are sent to a single federal court for pre-trial proceedings, but then sent back for trial to the courts in which they were filed. For the many women injured by YAZ, Yasmin and Ocella side effects, this is a positive development, because it allows them and their attorneys to pool their resources against corporate giant Bayer, which manufactures YAZ and Yasmin.
If you or a loved one has suffered from a YAZ side effect, Yasmin side effect, or Ocella side effect, you may contact the YAZ lawyers and YAZ attorneys at DeCarli Law for a free consultation to learn about your legal rights.
|
|
| Continue reading "Multidistrict Litigation (“MDL”) Court Created for YAZ Birth Control Lawsuits" » |
|
| Permalink |
| |
| 4 entries found. Viewing page 1 of 1. |
| | |